News
Leerink Partners analyst Andrew Berens maintained a Hold rating on Elevation Oncology (ELEV – Research Report) on April 16. The company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback